Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zimmer Holdings (NY:ZBH)

91.85 +0.74 (+0.81%)
Official Closing Price Updated: 7:00 PM EDT, Jun 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zimmer Holdings

< Previous 1 2 3 4 5 6 7 8 9 Next >
Stryker, NextEra Energy And A Stock Down 18% In Past Month: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Josh Brown of Ritholtz Wealth Management said he is sticking with NextEra Energy, Inc. (NYSE: NEE) 
Via Benzinga
3M Deepens Bench, Fills CEO, CFO And Other C-Suite Positions At Healthcare Spinoff
3M Co (NYSE: MMM) set several leadership positions for its independent healthcare company  
Via Benzinga
The 7 Most Undervalued Healthcare Stocks to Buy Now: August 2023
All of these healthcare stocks to buy are underpriced and relatively stable investments over the mid-to-long term. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
How Is The Market Feeling About Zimmer Biomet Holdings?
Via Benzinga
Zimmer Biomet Clocks 5% Revenue Growth In Q2, Raises Annual Guidance
Zimmer Biomet Holdings, Inc. (NYSE: ZBH) reported Q2 FY23 adjusted EPS of $1.82,  
Via Benzinga
A Look Into Zimmer Biomet Holdings' Debt
Via Benzinga
Expert Ratings for Zimmer Biomet Holdings
Via Benzinga
Looking Into Zimmer Biomet Holdings's Recent Short Interest
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Jim Cramer Says Sell Activision And 'Roll' Your Profits Into This 'Incredibly Cheap' Video Game Company
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Zimmer Biomet Holdings, Inc. (NYSE: ZBH). 
Via Benzinga
Where Zimmer Biomet Holdings Stands With Analysts
Via Benzinga
DexCom Clears Base, Wall Street Eyes Double-Digit Earnings Growth
DexCom's G7 glucose-monitoring solution is driving revenue growth at the company. Analysts expect strong double-digit EPS growth this year and next. 
Via MarketBeat
Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand
Surgery centers and medtech firms see a surge in demand as joint replacements and other elective surgeries are rescheduled, causing challenges for insurers. 
Via MarketBeat
What 16 Analyst Ratings Have To Say About Zimmer Biomet Holdings
Via Benzinga
Baird Maintains Outperform Rating for Zimmer Biomet Holdings: Here's What You Need To Know
Via Benzinga
Zimmer Biomet, InMode And The World's Largest Investment Firm: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Stephanie Link of Hightower said Zimmer Biomet Holdings, Inc. 
Via Benzinga
UnitedHealth's Bad News Hits Insurers, But Surgery Partners Signals Breakout
UNH stock slumped after UnitedHealth said more seniors are getting hip and surgery procedures. That sent Surgery Partners stock soaring. 
Via Investor's Business Daily
3 High-Reward Stocks Riding the Healthcare Boom
Healthcare stocks are a great option for long-term investors that want to ride out economic uncertainty and capitalize on the aging population. 
Via InvestorPlace
3 Stocks That Are Reshaping the Future
As the population ages and AI develops, these three companies stand out among stocks reshaping the future. 
Via InvestorPlace
Where Zimmer Biomet Holdings Stands With Analysts
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2023
Via Benzinga
Zimmer Biomet Holdings Earnings Conference Call Is Coming Up, Here's What You Need To Know
Via Benzinga
Market Rally Finishes Strong; Regional Banks, Fed Rate Hike, Jobs Report, Apple In Focus: Weekly Review
The major indexes retreated for most of the week on banking fears, 
Via Investor's Business Daily
AMD To Rally Around 32%? Here Are 10 Other Analyst Forecasts For Wednesday
Needham cut the price target for Zebra Technologies Corporation (NASDAQ: ZBRA) from $385 to $340. Needham analyst James Ricchiuti maintained a Buy rating. Zebra Technologies shares fell 11.1% to close... 
Via Benzinga
Shockwave Medical Gets 10% Jolt, Leads Medical Gear Makers Higher
Shockwave got a 10.64% jolt on a proposed Medicare change that could up the usage of its gear. Other medical product makers are forming bullish consolidations. 
Via MarketBeat
Benzinga's Top Ratings Upgrades, Downgrades For April 11, 2023
Via Benzinga
NVIDIA To Rally Around 16%? Here Are 10 Other Analyst Forecasts For Tuesday
Truist Securities boosted the price target for Murphy Oil Corporation (NYSE: MUR) from $49 to $56. Truist Securities analyst Neal Dingmann upgraded the stock from Hold to Buy. Murphy Oil shares rose 1%... 
Via Benzinga
Minimally Invasive Surgery — This Company's Successful Trial Could Help Eliminate The Need For An Incision In Patients With Back Pain
As medical technology progresses, the world’s approach to surgical operations is also advancing and changing significantly. As part of this, minimally invasive surgery (MIS), in recent years, has taken... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS